Effects of Haemodialysis on Serum Lipid Profile in Patients with Chronic Kidney Disease

Sadia  Kiran; Muhammad Anwar; Muhammad Qaiser Alam Khan; Muhammad  Younas; Sajida Shaheen; Asif Ali

doi:10.51253/pafmj.v76i4.12544

Authors

Sadia Kiran Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Muhammad Anwar Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Muhammad Qaiser Alam Khan Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Muhammad Younas Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Sajida Shaheen Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Asif Ali Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76i4.12544

Keywords:

Chronic Kidney disease, Conservative management, Hemodialysis, Lipid parameters

Abstract

Objective: To compare the lipid parameters in Chronic Kidney disease patients undergoing haemodialysis with those on conservative management.

Study Design: Comparative cross sectional study.

Place and Duration of Study: Chemical Pathology and Endocrinology Department, Armed Forces Institute of Pathology, Rawalpindi, Pakistan from Jul to Dec 2023.

Methodology: The study was conducted on Chronic Kidney disease (CKD) patients. Blood sample was collected in gel bottles and centrifuged at 3000 revolution per minute for 5 minutes. The lipid profile and Renal Function Tests (RFTs) were analyzed on clinical chemistry auto-analyzer.

Results: A total of 257 patients of CKD, 147 on conservative management (Group A) and 110 on hemodialysis (Group B) were selected. Patients on hemodialysis with advance CKD, displayed significantly elevated median Total Cholesterol (4.67mmol/L versus 3.48mmol/L), LDL-Cholesterol (2.53mmol/L versus 1.80mmol/L), Non-HDL Cholesterol (3.71mmol/L versus 2.48mmol/L), Non-HDL to HDL-Cholesterol ratio (3.99mmol/L versus 2.36mmol/L) and Triglyceride (1.98mmol/L versus 1.54mmol/L)(p<0.05), while HDL-Cholesterol (0.81mmol/L versus 1.01mmol/L)was significantly lower (p<0.001) as compared to conservative managed patients. Total Cholesterol, LDL-Cholesterol, Non-HDL-Cholesterol, and Non-HDL to HDL-Cholesterol ratio showed significant positive association with serum creatinine, while HDL-Cholesterol exhibited a negative correlation with serum creatinine (p<0.05).

Conclusion: The progression of dyslipidemia is directly related to the stages of CKD. Therefore, early monitoring of lipid profiles in patients on hemodialysis with advance CKD is crucial to decrease risk which may reduce mortality and morbidity associated with cardiovascular disease among these patients.

Downloads

Download data is not yet available.

References

1. Gai Z, Wang T, Visentin M, Kullak-Ublick GA, Fu X, Wang Z. Lipid accumulation and chronic kidney disease. Nutrients 2019; 11(4): 722. http://doi.org/10.3390/nu11040722

2. Saini M, Vamne A, Kumar V, Chandel MS. The study of pattern of lipid profile in chronic kidney disease patients on conservative management and hemodialysis: a comparative study. Cureus 2022; 14(1): e21506.

http://doi.org/10.7759/cureus.21506

3. Bawakhan BH, Chandru MC, Moger V. A study of lipid profile in maintenance hemodialysis patients. Int J Clin Biochem Res 2020; 7(2): 172-175.

http://doi.org/10.18231/j.ijcbr.2020.037

4. Baqi HR, Rostam SRK. The correlation between lipid profile and renal function tests in patients with cardiovascular disease in Erbil city, Kurdistan region of Iraq. Kurd J Appl Res 2020; 5(2): 51-59. http://doi.org/10.24017/science.2020.2.5

5. Patil S, Kumar VA, Subramani S. To evaluate lipid profiles in patients with chronic kidney disease in Raja Rajeswari Medical College and Hospital, Bengaluru, Karnataka, India. J Med Sci 2018; 4(2): 31-34.

http://doi.org/10.5005/jp-journals-10045-0080

6. Johnson RJ, Floege J, Tonelli M. Comprehensive clinical nephrology. 7th edition- Health Sciences Division. Philadelphia, PA: Elsevier 2023.

7. Bulbul MC, Dagel T, Afsar B, Ulusu NN, Kuwabara M, Covic A, et al. Disorders of lipid metabolism in chronic kidney disease. Blood Purif 2018; 46(2): 144-52.

http://doi.org 10.1159/000488816

8. Hangargekar P, Jha D, Akbar M, Pawar S, Joshi A. Exploring non-high-density lipoprotein estimation methods and their clinical significance in cardiovascular disease. Adv Pharm J 2023; 8(2): 37-42.

http://doi.org10.31024/apj.2023.8.2.1

9. Visconti L, Benvenga S, Lacquaniti A, Cernaro V, Bruzzese A, Conti G, et al. Lipid disorders in patients with renal failure: role in cardiovascular events and progression of chronic kidney disease. J Clin Transl Endocrinol 2016; 6:8-14.

http://doi.org 10.1016/j.jcte.2016.08.002

10. Imtiaz S, Alam A. Epidemiology and demography of Chronic Kidney Disease in Pakistan- A review of Pakistani literature. Pak J Kidney Dis 2023; 7(1): 2-7. http://doi.org 10.53778/pjkd71209

11. Hasan M, Sutradhar I, Gupta RD, Sarker M. Prevalence of chronic kidney disease in South Asia: a systematic review. BMC Nephrol 2018; 19(1): 291.

http://doi.org 10.1186/s12882-018-1072-5

12. Choudhary N. A study of lipid profile in chronic kidney disease in pre-dialysis patients. Int J Med Res Rev 2019; 7(3): 150-6.

http://doi.org10.17511/ijmrr.2019.i03.01

13. Singh S, Pathak AK, Parappanavar NU. A study of fasting lipid profile in chronic kidney disease patients. Int J Res Med Sci 2019; 7(6): 2282-2285.

http://doi.org 10.18203/2320-6012.ijrms20192513

14. Muhammed SAV, Shifa K, Vipindas K. Comparative study of lipid profile in patients with chronic kidney disease on haemodialysis / conservative management with control population. Am J Biochem 2019; 9(2): 17-20.

http://doi.org 10.5923/j.ajb.20190902.0115

15. Kumari KR, Srinivas B. Study of lipid profile in patients with chronic kidney disease on conservative management and hemodialysis. Int J Sci Stud 2018; 6: 108-113.

16. Ganta V, Yalamanchi R, Sahu B, Raghvendar K, Anusha G. A study of lipid profile in non-diabetic chronic kidney disease. Int J Adv Med 2016; 3(4): 965-970.

http://doi.org 10.18203/2349-3933.ijam20163732

17. Barbagallo CM, Cefalù AB, Giammanco A, Noto D, Caldarella R, Ciaccio M, et al. Lipoprotein abnormalities in chronic kidney disease and renal transplantation. Life (Basel) 2021; 11(4): 315.

http://doi.org 10.3390/life11040315

18. Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol 2023; 13(2): 367-369. http://doi.org10.5455/njppp.2023.13.12597202220122022

19. Kazi D, Hussain J, Husain W, Husain A, Khaleel M. Dyslipidemia in chronic renal failure and its implications in associated cardiovascular disease. J Cardiovasc Dis Res 2022; 13(5): 1439-1448. https://doi.org/10.48047/

20. Anwar S, Zainab A, Mazhar S. Lipid abnormalities using random sampling in patients with end stage renal disease on thrice weekly hemodialysis. Pak J Kidney Dis 2020; 4(4): 328-331.

http://doi.org 10.53778/pjkd4431

21. Pontremoli R, Bellizzi V, Bianchi S, Bigazzi R, Cernaro V, Del Vecchio L, et al. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology. J Nephrol 2020; 33(3): 417-430.

http://doi.org 10.1007/s40620-020-00707-2

22. Mehta A. Managing dyslipidemia in solid organ transplant patients. Indian Heart J 2024; 76(Suppl 1): S93-95.

http://doi.org10.1016/j.ihj.2024.01.004

23. Liao S, Lin D, Feng Q, Li F, Qi Y, Feng W, et al. Lipid parameters and the development of chronic kidney disease: a prospective cohort study in middle-aged and elderly Chinese individuals. Nutrients 2023; 15(1): 112. http://doi.org 10.3390/nu15010112